Works matching IS 00070920 AND DT 2003 AND VI 89 AND IP 10

Results: 35

Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells.

Published in:

2003

By:

Eves, P;
Haycock, J;
Layton, C;
Wagner, M;
Kemp, H;
Szabo, M;
Morandini, R;
Ghanem, G;
García-Borrón, J C;
Jiménez-Cervantes, C;
Mac Neil, S

Publication type:

journal article

Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia.

Published in:

2003

By:

O'Brien, S. G.;
Meinhardt, P.;
Bond, E.;
Beck, J.;
Peng, B.;
Dutreix, C.;
Mehring, G.;
milosavljev, S.;
Huber, C.;
Capdeville, R.;
Fischer, T.

Publication type:

journal article

Experiences of men with breast cancer: an exploratory focus group study.

Published in:

2003

By:

Williams, B. G.;
Iredale, R.;
Brain, K.;
France, E.;
Barrett-Lee, P.;
Gray, J.

Publication type:

journal article

Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development.

Published in:

British Journal of Cancer, 2003, v. 89, n. 10, p. 1817, doi. 10.1038/sj.bjc.6601327

By:

Hojilla, C. V.;
Mohammed, F. F.;
Khokha, R.

Publication type:

Article

Study of in vitro and in vivo effects of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a novel cytostatic and differentiation inducing agent, on human colon cancer cells.

Published in:

2003

By:

Wang, J. J.;
Chang, Y. F.;
Chern, Y. T.;
Chi, C. W.

Publication type:

journal article

Anti-inflammatory and anti-invasive effects of a-melanocyte-stimulating hormone in human melanoma cells.

Published in:

British Journal of Cancer, 2003, v. 89, n. 10, p. 2004, doi. 10.1038/sj.bjc.6601349

By:

Eves, P.;
Haycock, J.;
Layton, C.;
Wagner, M.;
Kemp, H.;
Szabo, M.;
Morandini, R.;
Ghanem, G.;
García-Borrón, J. C.;
Jiménez-Cervantes, C.;
Mac Neil, S.

Publication type:

Article

Extended duration of the detectable stage by adding HPV test in cervical cancer screening.

Published in:

2003

By:

van den Akker-van Marie, M. E.;
van Ballegooijen, M.;
Rozendaal, L.;
Meijer, C. J. L. M.;
Habbema, J. D. F.

Publication type:

journal article

Role of MC1R variants in uveal melanoma.

Published in:

2003

By:

Hearle, N.;
Humphreys, J.;
Damato, B. E.;
Wort, R.;
Talaban, R.;
Wixey, J.;
Green, H.;
Easton, D.F.;
Houlston, R.S.

Publication type:

journal article

Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma.

Published in:

2003

By:

Campbell, L.;
Gumbleton, M.;
Griffiths, D. F. R.

Publication type:

journal article

Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity.

Published in:

2003

By:

Neuzil, J.

Publication type:

journal article

Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity.

Published in:

2003

By:

Seymour, C. B.;
Mothersill, C.;
Mooney, R.;
Moriarty, M.;
Tipton, K. F.

Publication type:

journal article

Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer.

Published in:

2003

By:

Azria, D.;
Larbouret, C.;
Garambois, V.;
Kramar, A.;
Martineau, P.;
Robert, B.;
Aillères, N.;
Yochou, M.;
Dubois, J. B.;
Pèlegrin, A.;
Aillères, N;
Ychou, M;
Pèlegrin, A

Publication type:

journal article

Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer.

Published in:

2003

By:

Cameron, D. A.;
Massie, C.;
Kerr, G.;
Leonard, R. C. F.

Publication type:

journal article

Evaluation of various cytological examinations by bronchoscopy in the diagnosis of peripheral lung cancer.

Published in:

British Journal of Cancer, 2003, v. 89, n. 10, p. 1885, doi. 10.1038/sj.bjc.6601368

By:

Kawaraya, M.;
Gemba, K.;
Ueoka, H.;
Nishii, K.;
Kiura, K.;
Kodani, T.;
Tabata, M.;
Shibayama, T.;
Kitajima, T.;
Tanimoto, M.

Publication type:

Article

Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma.

Published in:

2003

By:

Guan, Z.;
Wang, Y.;
Maoleekoonpairoj, S.;
Chen, Z.;
Kim, W. S.;
Ratanatharathorn, V.;
Reece, W. H. H.;
Kim, T. W.;
Lehnert, M.

Publication type:

journal article

Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity.

Published in:

2003

By:

Robey, R. W.;
Honjo, Y.;
Morisaki, K.;
Nadjem, T. A.;
Runge, S.;
Risbood, M.;
Poruchynsky, M. S.;
Bates, S. E.

Publication type:

journal article

BRAF mutations in non-Hodgkin's lymphoma.

Published in:

British Journal of Cancer, 2003, v. 89, n. 10, p. 1958, doi. 10.1038/sj.bjc.6601371

By:

Lee, J. W.;
Yoo, N. J.;
Soung, Y. H.;
Kim, H. S.;
Park, W. S.;
Kim, S. Y.;
Lee, J. H.;
Park, J. Y.;
Cho, Y. G.;
Kim, C. J.;
Ko, Y. H.;
Kim, S. H.;
Nam, S. W.;
Lee, J. Y.;
Lee, S. H.

Publication type:

Article

Differential expression profiling of head and neck squamous cell carcinoma (HNSCC).

Published in:

2003

By:

Lemaire, F.;
Millon, R.;
Young, J.;
Cromer, A.;
Wasylyk, C.;
Schultz, I.;
Muller, D.;
Marchal, P.;
Zhao, C.;
Melle, D.;
Bracco, L.;
Abecassis, J.;
Wasylyk, B.

Publication type:

journal article

Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development.

Published in:

British Journal of Cancer, 2003, v. 89, n. 10, p. 1914, doi. 10.1038/sj.bjc.6601374

By:

Zuidervaart, W.;
van der Velden, P. A.;
Hurks, M. H.;
van Nieuwpoort, F. A.;
Out-Luiting, C. J. J.;
Singh, A. D.;
Frants, R. R.;
Jager, M. J.;
Gruis, N. A.

Publication type:

Article

Promising survival for patients with glioblastoma multiforme treated with individualised chemotherapy based on in vitro drug sensitivity testing.

Published in:

2003

By:

Iwadate, Y.;
Fujimoto, S.;
Namba, H.;
Yamaura, A.

Publication type:

journal article

Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus interleukin-2: induction of autologous tumor-reactive CD4+ Th1 killer lymphocytes.

Published in:

2003

By:

Yamaguchi, Y.;
Miyahara, E.;
Ohshita, A.;
Kawabuchi, Y.;
Ohta, K.;
Shimizu, K.;
Minami, K.;
Hihara, J.;
Sawamura, A.;
Toge, T.

Publication type:

journal article

A phase II irinotecan-cisplatin combination in advanced pancreatic cancer.

Published in:

2003

By:

Markham, C.;
Stocken, D. D.;
Hassan, A. B.

Publication type:

journal article

A phase II trial of capecitabine (Xeloda) in recurrent ovarian cancer.

Published in:

2003

By:

Vasey, P. A.;
McMahon, L.;
Paul, J.;
Reed, N.;
Kaye, S. B.

Publication type:

journal article

A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients.

Published in:

2003

By:

Garufi, C.;
Bria, E.;
Vanni, B.;
Zappal&grave;, A. M. R.;
Sperduti, I.;
Terzoli, E.;
Zappalà, A M R

Publication type:

journal article

Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up study.

Published in:

2003

By:

Gaffan, J.;
Holden, L.;
Newlands, E. S.;
Short, D.;
Fuller, S.;
Begent, R. H. J.;
Rustin, G. J. S.;
Seckl, M. J.

Publication type:

journal article

Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours.

Published in:

2003

By:

Checkley, D.;
Tessier, J. J.;
Kendrew, J.;
Waterton, J. C.;
Wedge, S. R.

Publication type:

journal article

Gefitinib in elderly and unfit patients affected by advanced non-small-cell lung cancer.

Published in:

2003

By:

Gridelli, C.;
Maione, P.;
Castaldo, V.;
Rossi, A.

Publication type:

journal article

Traditional behavioural practices, the exchange of saliva and HHV-8 transmission in sub-Saharan African populations.

Published in:

2003

By:

Wojcicki, J. M.

Publication type:

Letter

MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status.

Published in:

British Journal of Cancer, 2003, v. 89, n. 10, p. 1934, doi. 10.1038/sj.bjc.6601392

By:

M&uulm;ller, H. M.;
Fiegl, H.;
Goebel, G.;
Hubalek, M. M.;
Widschwendter, A.;
Müller-Holzner, E.;
Martin, C.;
Widschwendter, M.

Publication type:

Article

Defects in death-inducing signalling complex formation prevent JNK activation and Fas-mediated apoptosis in DU 145 prostate carcinoma cells.

Published in:

British Journal of Cancer, 2003, v. 89, n. 10, p. 1950, doi. 10.1038/sj.bjc.6601393

By:

Curtin, J. F.;
Cotter, T. G.

Publication type:

Article

Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer.

Published in:

2003

By:

Oehler, M. K.;
Fischer, D. C.;
Orlowska-Volk, M.;
Herrle, F.;
Kieback, D. G.;
Rees, M. C. P.;
Bicknell, R.

Publication type:

journal article

Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence.

Published in:

2003

By:

Jirstr&oulm;m, K.;
Ringberg, A.;
Fern&oulm;, M.;
Anagnostaki, L.;
Landberg, G.;
Jirström, K;
Fernö, M

Publication type:

journal article

The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer.

Published in:

2003

By:

Bromwich, E. J.;
McArdle, P. A.;
Canna, K.;
McMillan, D. C.;
McNicol, A.-M.;
Brown, M.;
Aitchison, M.

Publication type:

journal article

A phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanoma.

Published in:

2003

By:

Strauss, S. J.;
Marples, M.;
Napier, M. P.;
Meyer, T.;
Boxall, J.;
Rustin, G. J. S.

Publication type:

journal article

CHEK2 variants associate with hereditary prostate cancer.

Published in:

British Journal of Cancer, 2003, v. 89, n. 10, p. 1966, doi. 10.1038/sj.bjc.6601425

By:

Seppälä, E. H.;
Ikonen, T.;
Mononen, N.;
Autio, V.;
Rökman, A.;
Matikainen, M. P.;
Tammela, T. L. J.;
Schleutker, J.

Publication type:

Article